ScreenerHero
ABDXAbingdon Health Plc
LSE · GB · Healthcare · Diagnostics & Research · abingdonhealth.com
11.00GBP+4.76%Mkt Cap: 35.42M $P/E: —

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturi…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap35.42M $
Enterprise Value57.61M $
Revenue (TTM)12.28M $
Gross Profit4.79M $
Net Income (TTM)-4.38M $
Revenue/Share0.0321 USD
Last Price11.00 GBP
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees129
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)210.00
PEG—
EV/EBITDA-13.13
EV/Revenue4.69
P/S2.77
P/B7.00
EPS (TTM)-0.01
EPS (Forward)0.00
52W Range
0.000085% of range13.00
52W High13.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin44.32%
Oper. Margin-53.88%
EBITDA Margin-35.73%
Profit Margin-40.51%
ROE-64.43%
ROA-36.67%
Growth
Revenue Growth36.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.08M $
CapEx (TTM)443.78K $
FCF Margin-15.34%
FCF Yield-5.32%
Net Debt-3.54M $
Net Debt/EBITDA0.81
Balance Sheet
Debt/Equity0.19
Current Ratio1.91
Quick Ratio1.73
Book Value/Sh0.0150 GBP
Cash/Share0.0090 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)19.00 GBP
Upside (mean)+72.7%
Target Range19.00 GBP – 19.00 GBP
# Analysts1
Ownership
Shares Out.252.75M
Float168.65M
Insiders30.43%
Institutions31.57%
Technical
SMA 5010.46 (+5.2%)
SMA 2008.630 (+27.5%)
Beta0.13
S&P 52W Chg18.16%
Avg Vol (30d)94.44K
Avg Vol (10d)64.74K
Technical Indicators
RSI (14)67.0
MACD0.0602
MACD Signal-0.0379
MACD Hist.+0.0981
BB Upper11.00 GBP
BB Middle10.26 GBP
BB Lower9.510 GBP
BB Width14.55%
ATR (14)0.8391 GBP
Vol Ratio (20d)1.66x